We are pleased to present the final webinar in this first series relating to Goodwin’s Guide to Biosimilars Litigation and Regulation in the U.S., which provides expert guidance and practical know-how for lawyers working in this growing area of the law.
This webinar, An Overview of the Biosimilars Market in China, will take place Wednesday, January 19th. Goodwin’s Huiya Wu and Freddy Yip will provide an overview of the players, products, and regulatory and legal schemes of the biosimilars market in China and how it compares to the U.S. market.
To learn more about all of the webinars in this series, click here.
The post Upcoming Webinar – An Overview of the Biosimilars Market in China appeared first on Big Molecule Watch.